HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity.

Abstract
Variation in the formation and disposition of the hydroxylamine of (SMX-HA) is thought to play an important role in the pathogenesis of sulfamethoxazole (SMX)-induced idiosyncratic adverse drug reactions. We hypothesized that, in analogy to carcinogenic arylamines, SMX-HA might be further converted to an electrophilic N-acetoxy metabolite which could play a role in mediating SMX toxicity. Accordingly, we chemically synthesized N-acetoxy-SMX, and examined the characteristics of its formation, metabolism, cytotoxicity and mutagenicity in human and bacterial test systems. The human arylamine N-acetyl-transferases, (NAT)1 and NAT2, were capable of converting SMX-HA to N-acetoxy-SMX. NAT1 and NAT2 possessed similar affinities for SMX-HA (apparent Km values of 650 and 520 microM, respectively), but the apparent maximal velocity of the NAT1-mediated acetylation was higher than that of NAT2. (1332 vs. 37 nmol/min/U of immunoreactive NAT protein). Human peripheral blood mononuclear cells 12,000 x g supernatant fractions converted N-acetoxy-SMX mainly back to SMX-HA, and also to a lesser extent to SMX, at clinically relevant concentrations. Similar pathways were observed in human hepatic cytosolic fractions. In a cytotoxicity assay, N-acetoxy-SMX was significantly more toxic to human peripheral blood mononuclear cells than SMX-HA (16.6 vs. 11.5% dead cells at a concentration of 300 microM). N-acetoxy-SMX was weakly mutagenic to the Salmonella typhimurium TA100 strain in the Ames test. These data suggest that the N-acetoxy metabolites of sulfonamides could potentially play a role in mediating sulfonamide idiosyncratic adverse drug reactions.
AuthorsH Nakamura, J Uetrecht, A E Cribb, M A Miller, N Zahid, J Hill, P D Josephy, D M Grant, S P Spielberg
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 274 Issue 3 Pg. 1099-104 (Sep 1995) ISSN: 0022-3565 [Print] United States
PMID7562475 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hydroxamic Acids
  • N-acetoxysulfamethoxazole
  • Recombinant Proteins
  • Acetyltransferases
  • Sulfamethoxazole
Topics
  • Acetyltransferases (metabolism)
  • Biotransformation
  • Cytosol (enzymology)
  • Humans
  • Hydroxamic Acids (metabolism)
  • In Vitro Techniques
  • Leukocytes, Mononuclear (metabolism)
  • Liver (enzymology)
  • Mutagenicity Tests
  • Recombinant Proteins (metabolism)
  • Salmonella typhimurium (genetics)
  • Sulfamethoxazole (analogs & derivatives, metabolism, pharmacokinetics, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: